These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 33521237)
1. Myocardial fibrosis in patients with a history of Kawasaki disease. Dusenbery SM; Newburger JW; Colan SD; Gauvreau K; Baker A; Powell AJ Int J Cardiol Heart Vasc; 2021 Feb; 32():100713. PubMed ID: 33521237 [TBL] [Abstract][Full Text] [Related]
2. Diffusely Increased Myocardial Extracellular Volume With or Without Focal Late Gadolinium Enhancement: Prevalence and Associations With Left Ventricular Size and Function. Lundin M; Sörensson P; Maret E; Jenner J; Abdula G; Nickander J; Themudo R; Caidahl K; Kellman P; Sigfridsson A; Ugander M J Thorac Imaging; 2022 Jan; 37(1):17-25. PubMed ID: 32271280 [TBL] [Abstract][Full Text] [Related]
3. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257 [TBL] [Abstract][Full Text] [Related]
4. Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping. Gong C; Guo J; Wan K; Wang L; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen C; Chen Y J Cardiovasc Magn Reson; 2022 Nov; 24(1):60. PubMed ID: 36404313 [TBL] [Abstract][Full Text] [Related]
5. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119 [TBL] [Abstract][Full Text] [Related]
6. Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in hypertension and associated with left ventricular remodeling. Wang S; Hu H; Lu M; Sirajuddin A; Li J; An J; Chen X; Yin G; Lan T; Dai L; Zhang Y; Yin X; Song L; Dang A; Kellman P; Arai AE; Zhao S Eur Radiol; 2017 Nov; 27(11):4620-4630. PubMed ID: 28439652 [TBL] [Abstract][Full Text] [Related]
7. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. Dusenbery SM; Jerosch-Herold M; Rickers C; Colan SD; Geva T; Newburger JW; Powell AJ J Am Coll Cardiol; 2014 May; 63(17):1778-85. PubMed ID: 24632273 [TBL] [Abstract][Full Text] [Related]
9. Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance. Barison A; Gargani L; De Marchi D; Aquaro GD; Guiducci S; Picano E; Cerinic MM; Pingitore A Eur Heart J Cardiovasc Imaging; 2015 Jan; 16(1):74-80. PubMed ID: 25190071 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of extracellular volume fraction thresholds corresponding to myocardial late-gadolinium enhancement using cardiac magnetic resonance. Hwang SH; Choi EY; Park CH; Paek MY; Greiser A; Kim TH; Choi BW Int J Cardiovasc Imaging; 2014 Dec; 30 Suppl 2():137-44. PubMed ID: 25022430 [TBL] [Abstract][Full Text] [Related]
11. CMR T Zhao P; Huang L; Ran L; Tang D; Zhou X; Xia L Eur Radiol; 2021 Mar; 31(3):1206-1215. PubMed ID: 32876836 [TBL] [Abstract][Full Text] [Related]
12. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. aus dem Siepen F; Buss SJ; Messroghli D; Andre F; Lossnitzer D; Seitz S; Keller M; Schnabel PA; Giannitsis E; Korosoglou G; Katus HA; Steen H Eur Heart J Cardiovasc Imaging; 2015 Feb; 16(2):210-6. PubMed ID: 25246502 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis). Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886 [TBL] [Abstract][Full Text] [Related]
14. Myocardial Fibrosis in Competitive Triathletes Detected by Contrast-Enhanced CMR Correlates With Exercise-Induced Hypertension and Competition History. Tahir E; Starekova J; Muellerleile K; von Stritzky A; Münch J; Avanesov M; Weinrich JM; Stehning C; Bohnen S; Radunski UK; Freiwald E; Blankenberg S; Adam G; Pressler A; Patten M; Lund GK JACC Cardiovasc Imaging; 2018 Sep; 11(9):1260-1270. PubMed ID: 29248656 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of macroscopic and microscopic myocardial fibrosis by cardiac MR: intra-individual comparison of gadobutrol versus gadoterate meglumine. Rahsepar AA; Ghasemiesfe A; Suwa K; Dolan RS; Shehata ML; Korell MJ; Naresh NK; Markl M; Collins JD; Carr JC Eur Radiol; 2019 Aug; 29(8):4357-4367. PubMed ID: 30617490 [TBL] [Abstract][Full Text] [Related]
16. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot. Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969 [TBL] [Abstract][Full Text] [Related]
17. Extracellular volume-guided late gadolinium enhancement analysis for non-ischemic cardiomyopathy: The Women's Interagency HIV Study. Kato Y; Kizer JR; Ostovaneh MR; Lazar J; Peng Q; van der Geest RJ; Lima JAC; Ambale-Venkatesh B BMC Med Imaging; 2021 Jul; 21(1):116. PubMed ID: 34315432 [TBL] [Abstract][Full Text] [Related]
18. The apparent diffusion coefficient is strongly correlated with extracellular volume, a measure of myocardial fibrosis, and subclinical cardiomyopathy in patients with systemic lupus erythematosus. Wu R; An DA; Hu J; Jiang M; Guo Q; Xu JR; Wu LM Acta Radiol; 2018 Mar; 59(3):287-295. PubMed ID: 28679323 [TBL] [Abstract][Full Text] [Related]
19. Prediction of the estimated 5-year risk of sudden cardiac death and syncope or non-sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy using late gadolinium enhancement and extracellular volume CMR. Avanesov M; Münch J; Weinrich J; Well L; Säring D; Stehning C; Tahir E; Bohnen S; Radunski UK; Muellerleile K; Adam G; Patten M; Lund G Eur Radiol; 2017 Dec; 27(12):5136-5145. PubMed ID: 28616729 [TBL] [Abstract][Full Text] [Related]
20. Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation. Neilan TG; Mongeon FP; Shah RV; Coelho-Filho O; Abbasi SA; Dodson JA; McMullan CJ; Heydari B; Michaud GF; John RM; Blankstein R; Jerosch-Herold M; Kwong RY JACC Cardiovasc Imaging; 2014 Jan; 7(1):1-11. PubMed ID: 24290570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]